1. Home
  2. BNC vs CGEM Comparison

BNC vs CGEM Comparison

Compare BNC & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNC
  • CGEM
  • Stock Information
  • Founded
  • BNC N/A
  • CGEM 2016
  • Country
  • BNC United States
  • CGEM United States
  • Employees
  • BNC N/A
  • CGEM N/A
  • Industry
  • BNC Industrial Machinery/Components
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNC Industrials
  • CGEM Health Care
  • Exchange
  • BNC Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • BNC 406.7M
  • CGEM 437.2M
  • IPO Year
  • BNC N/A
  • CGEM 2021
  • Fundamental
  • Price
  • BNC $7.70
  • CGEM $7.85
  • Analyst Decision
  • BNC
  • CGEM Strong Buy
  • Analyst Count
  • BNC 0
  • CGEM 7
  • Target Price
  • BNC N/A
  • CGEM $26.00
  • AVG Volume (30 Days)
  • BNC 1.5M
  • CGEM 1.5M
  • Earning Date
  • BNC 11-13-2025
  • CGEM 11-07-2025
  • Dividend Yield
  • BNC N/A
  • CGEM N/A
  • EPS Growth
  • BNC N/A
  • CGEM N/A
  • EPS
  • BNC N/A
  • CGEM N/A
  • Revenue
  • BNC $4,027,431.00
  • CGEM N/A
  • Revenue This Year
  • BNC N/A
  • CGEM N/A
  • Revenue Next Year
  • BNC N/A
  • CGEM N/A
  • P/E Ratio
  • BNC N/A
  • CGEM N/A
  • Revenue Growth
  • BNC 27.46
  • CGEM N/A
  • 52 Week Low
  • BNC $5.60
  • CGEM $5.68
  • 52 Week High
  • BNC $82.88
  • CGEM $17.50
  • Technical
  • Relative Strength Index (RSI)
  • BNC 35.34
  • CGEM 56.01
  • Support Level
  • BNC $6.96
  • CGEM $7.69
  • Resistance Level
  • BNC $8.49
  • CGEM $8.69
  • Average True Range (ATR)
  • BNC 0.99
  • CGEM 0.63
  • MACD
  • BNC 0.31
  • CGEM 0.08
  • Stochastic Oscillator
  • BNC 14.17
  • CGEM 60.17

About BNC CEA Industries Inc. Common Stock

CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: